Active ingredientPirenoxineCat. No. P-P131-001CAS 1043-21-6Family · Pharmaceutical analytical standards
Pirenoxine
The active ingredient of eye drops developed in Japan and registered in 1958 for senile cataract, used for decades in Asia and other countries to protect lens proteins from clouding. This family brings together the active ingredient and other impurities.
Did you know?It grew out of the quinoid theory of Japan's S. Ogino, who in 1957 proposed that quinone-like substances make lens proteins insoluble: pirenoxine was meant to compete with them.
Go to the active ingredient →Active ingredientPirenoxineCat. No. P-P131-001CAS 1043-21-6
Impurity1,2,4-triethoxybenzeneCat. No. P-P131-002CAS 41827-15-0No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.